The American Society for 

Reproductive Immunology 

ASRI 2026 Election Nominees for Council

You must be an active ASRI member to vote!


Become a Member

VOTE NOW

Be sure to sign in to your ASRI account before clicking the Vote Now button.

Voting will close at 11:59 pm ET on Friday, May 22

Councilor Nominee

I am honored to express my interest in serving as a Council Member of ASRI. As the President of the Association of Reproductive Genetics and Immunology, India, my work has been deeply rooted in advancing the understanding and clinical application of reproductive immunology.


Over the years, I have actively worked in this field, helping manage thousands of patients with recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL), translating evolving scientific evidence into meaningful clinical outcomes. These experiences have strengthened my commitment to integrating emerging science with day-to-day fertility practice.


I believe ASRI provides a vital platform to promote evidence-based practice, academic exchange, and collaborative growth in reproductive medicine. As a Council Member, I would aim to contribute toward strengthening academic initiatives, fostering research in reproductive immunology, and supporting training for clinicians.


I look forward to contributing actively to ASRI’s vision of advancing excellence and innovation in reproductive healthcare.

Councilor Nominee

Dr. Gaddy is an Associate Professor of Medicine and Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center (VUMC).  Her research focuses on how the host responds to infection of the reproductive tract, specifically in the context of pregnancy.  Her latest work demonstrates that the bacterial pathogen Group B Streptococcus can highjack placental macrophage cells as a Trojan horse to ascend the gravid reproductive tract and cross the placenta to infect the developing fetus.  Dr. Gaddy’s current research program seeks to understand the host and environmental factors that contribute to susceptibility to perinatal infections and also to elucidate the antimicrobial molecules produced in human breast milk.  Dr. Gaddy would bring expertise in bacterial pathogenesis, innate immunity, and reproductive immunology and she utilizes cutting-edge techniques such as high-resolution imaging modalities (including electron microscopy), primary cell and tissue models, organ-on-a-chip models, preclinical animal models of disease, and multi-omics techniques in her research.  She has authored over 130 peer-reviewed manuscripts and is the Director of the Pre3 Initiative (Preventing Adverse Pregnancy Outcomes and Prematurity) and the Co-Director of the Women’s Reproductive Health Research Center at VUMC.  Dr. Gaddy is also a Burroughs Wellcome Fund Next Gen Pregnancy Awardee and a Fellow in the American Academy of Microbiology.

Full Bio

Councilor Nominee

Dr. Amy Gillgrass is an Assistant Professor in the Department of Microbiology and Immunology at the University of Dalhousie in Halifax, Canada.  Prior to this position, she had a lab at McMaster University (2019-2024), worked in Biotech and attained her PhD from McMaster University in Infection and Immunity.  Dr. Gillgrass’s research program involves immunology and infectious disease, with a focus on understanding immune responses and assessing novel therapeutics to prevent sexually transmitted infections in the female reproductive tract (HIV, HSV-2) using standard mice and next-generation humanized mouse models. In addition, she works on HIV/TB co-infection and vaccine development.  Her work is funded by Canadian health agencies including CIHR and CANFAR with high impact publications in Cell, NPJ Vaccines, Viruses and Frontiers in Immunology.  As an early career researcher, Dr. Gillgrass received the Bhagirath Singh Early Career Award in Infection and Immunity (CIHR) and the E.J. Moran Campbell Career Research Award.

Dr. Gillgrass has been part of ASRI meetings on and off for the last 20 years, first as a trainee and now as a PI.  She has presented at the meeting, been on the organizing committee, proposed and chaired sessions, been a member of the Awards Committee for several years and served on the Editorial Board of AJRI since 2019.  If elected as councillor, Dr. Gillgrass will promote the involvement of early career researchers in the society and maintain the welcoming and supportive environment of the ASRI meetings to help support the growth of investigators and promote collaborations.  Dr. Gillgrass would love to serve ASRI in this role. 

Full Bio

Councilor Nominee

I am honored to be nominated for the ASRI Council. As the Roger D. Rossen Endowed Professor of Reproductive Pathology at Baylor College of Medicine, my research focuses on the cellular and molecular mechanisms that regulate female reproductive health. My laboratory has identified novel links between gut microbiota, immune function, and endometriosis, as well as key interactions between autophagy, inflammation, and early pregnancy establishment. I have published more than 60 peer‑reviewed papers in leading journals, reflecting my commitment to advancing reproductive immunology.

For more than a decade, I have been an active and dedicated member of ASRI. I have served multiple terms on the Program Committee, contributing to scientific session planning, speaker recruitment, and meeting development, and I currently serve as Program Committee Chair for the 2026 ASRI Annual Meeting. I also contribute as an Associate Editor for the American Journal of Reproductive Immunology. As a councilor, I aim to strengthen collaboration, support early‑stage investigators, and expand partnerships with related societies. It would be a privilege to continue serving ASRI’s mission.

Councilor Nominee

Dr. Babbette LaMarca is a Professor and Chair of the Department of Pharmacology. She has served as Thesis Director of the Maternal-Fetal Medicine Fellowship Program in Obstetrics and Gynecology since 2007. Dr. LaMarca is also Co-Director and Pilot Program Director for the Mississippi Center of Excellence in Perinatal Research (COBRE) and Director of the Mississippi Preeclampsia (PE) Collaborative Center, funded by the SCORE grant. Dr. LaMarca has served as a peer reviewer for the American Heart Association (AHA), the Preeclampsia Foundation, and the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI). She previously chaired the AHA Clinical Endothelial and Vascular Biology: Clinical study section. She is an active member of the American Physiological Society (APS), where she has served on the Committee on Careers in Physiology and the Awards Committee, and she currently serves on the AHA Awards Committee.


Dr. LaMarca is Secretary of the International Society for the Study of Hypertension in Pregnancy (ISSHP) and serves on its organizing committee. She is also Co-Chair of the organizing committee for the International Society for Immunology of Reproduction (ISIR). In addition, she is an Associate Editor for Hypertension in Pregnancy and the American Journal of Reproductive Immunology and was a standing member of the NIH Obstetrics and Maternal-Fetal Biology Study Section.

She has been continuously funded by the NIH since 2005 and has published more than 140 peer-reviewed articles, in addition to presenting over 160 abstracts at national and international meetings.

Dr. LaMarca has received numerous honors, including the Young Investigator Award from the Inter-American Society of Hypertension (2012), the Young Scholars Award from the American Society of Hypertension, and Excellence in Research Awards from UMMC (Bronze 2010, Silver 2012, Gold 2013, and Platinum 2024). She was also awarded the prestigious Henry Pickering Bowditch Lectureship from APS (2015).


In 2021, she received the A. Clifford Barger Underrepresented Minority Mentorship Award from APS, followed by the 2022 LouAnn Woodward Late Career Award from GWIMS. She was also recognized as a Distinguished Alumna at UMMC. Most recently, Dr. LaMarca was named one of the five Billy S. Guyton Distinguished Professors at UMMC.

Although Dr. LaMarca has served on numerous organizing committees throughout her career, her recent work with ISIR and involvement with the American Society for Reproductive Immunology (ASRI) have been especially meaningful. The members of ASRI and ISIR have been highly welcoming to both her and her trainees, fostering strong professional relationships and collaborations. She has developed lasting friendships within these societies and would be honored to apply her experience and leadership to her new societal home.

Diversity & Inclusion: Our Foundation for Scientific Innovation

Many of the greatest ideas and discoveries come from a diverse mix of minds, backgrounds and experiences, and we are committed to cultivating an inclusive work environment. ASRI provides equal opportunities to all members and applicants for awards without regard to race, religion, color, age, sex, national origin, sexual orientation, gender identity, genetic disposition, neurodiversity, disability, veteran status or any other protected category under federal, state and local law.

Copyright © 2020 ASRI
Powered by Wild Apricot Membership Software